These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22171588)

  • 41. Controversies of anticoagulation reversal in life-threatening bleeds.
    Rolfe S; Papadopoulos S; Cabral KP
    J Pharm Pract; 2010 Jun; 23(3):217-25. PubMed ID: 21507817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Augmentation of thrombin generation in neonates undergoing cardiopulmonary bypass.
    Guzzetta NA; Szlam F; Kiser AS; Fernandez JD; Szlam AD; Leong T; Tanaka KA
    Br J Anaesth; 2014 Feb; 112(2):319-27. PubMed ID: 24193321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid reversal of warfarin-associated hemorrhage in the emergency department by prothrombin complex concentrates.
    Frumkin K
    Ann Emerg Med; 2013 Dec; 62(6):616-626.e8. PubMed ID: 23829955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.
    Aguilar MI; Hart RG; Kase CS; Freeman WD; Hoeben BJ; García RC; Ansell JE; Mayer SA; Norrving B; Rosand J; Steiner T; Wijdicks EF; Yamaguchi T; Yasaka M
    Mayo Clin Proc; 2007 Jan; 82(1):82-92. PubMed ID: 17285789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Economical comparison of APCC vs. rFVIIa for mild-to-moderate bleeding episodes in haemophilia patients with inhibitors.
    Hay JW; Zhou ZY
    Haemophilia; 2011 Sep; 17(5):e969-74. PubMed ID: 21649802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin.
    Dager WE; King JH; Regalia RC; Williamson D; Gosselin RC; White RH; Tharratt RS; Albertson TE
    Pharmacotherapy; 2006 Aug; 26(8):1091-8. PubMed ID: 16863486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversal of Oral Anticoagulants for Intracerebral Hemorrhage Patients: Best Strategies.
    Fuh L; Sin JH; Goldstein JN; Hayes BD
    Semin Respir Crit Care Med; 2017 Dec; 38(6):726-736. PubMed ID: 29262430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experiences in the prevention of arthropathy in haemophila patients with inhibitors.
    Jimenez-Yuste V; Rodriguez-Merchan EC; Alvarez MT; Quintana M; Martin-Salces M; Hernandez-Navarro F
    Haemophilia; 2008 Nov; 14 Suppl 6():28-35. PubMed ID: 19134031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors.
    Knight C; Danø AM; Kennedy-Martin T
    Haemophilia; 2009 Mar; 15(2):405-19. PubMed ID: 19187191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical usefulness of recombinant activated factor VII in patients with liver failure undergoing invasive procedures.
    Krisl JC; Meadows HE; Greenberg CS; Mazur JE
    Ann Pharmacother; 2011 Nov; 45(11):1433-8. PubMed ID: 22009992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemostatic agents for bleeding: recombinant-activated factor VII and beyond.
    Franchini M; Crestani S; Frattini F; Sissa C; Bonfanti C
    Semin Thromb Hemost; 2015 Apr; 41(3):342-7. PubMed ID: 24937097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency.
    Wiszniewski A; Szczepanik A; Misiak A; Bykowska K; Szopiński P
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):324-30. PubMed ID: 25688458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversing the new oral anticoagulants with prothrombin complex concentrates (PCCs): what is the evidence?
    Dickneite G; Hoffman M
    Thromb Haemost; 2014 Feb; 111(2):189-98. PubMed ID: 24136202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta-regression.
    Treur MJ; McCracken F; Heeg B; Joshi AV; Botteman MF; De Charro F; Van Hout B
    Haemophilia; 2009 Mar; 15(2):420-36. PubMed ID: 19335751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ex vivo reversal of effects of rivaroxaban evaluated using thromboelastometry and thrombin generation assay.
    Schenk B; Würtinger P; Streif W; Sturm W; Fries D; Bachler M
    Br J Anaesth; 2016 Nov; 117(5):583-591. PubMed ID: 27623677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Major surgery in severe haemophilia A with inhibitors using a recombinant factor VIIa and activated prothrombin complex concentrate hybrid regimen.
    van Veen JJ; Maclean RM; Hampton KK; Hamer A; Makris M
    Haemophilia; 2014 Jul; 20(4):587-92. PubMed ID: 24517157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
    Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
    J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents.
    Fukuda T; Honda Y; Kamisato C; Morishima Y; Shibano T
    Thromb Haemost; 2012 Feb; 107(2):253-9. PubMed ID: 22186946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retrospective evaluation of the clinical use of prothrombin complex concentrate for the reversal of anticoagulation with vitamin K antagonists.
    Cruz JL; Moss MC; Chen SL; Hansen KM; Amerine LB
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):378-82. PubMed ID: 25688457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding.
    Stewart WS; Pettit H
    Am J Emerg Med; 2013 Aug; 31(8):1251-4. PubMed ID: 23763937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.